**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7783-50-8 |Iron(III) fluoride, anhydrous | 98 | 232-002-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: C
Risk Phrases: 34
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Causes burns.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns. Inorganic fluorides can be
harmful. Acute exposure to fluorine compounds can lead to digestive
tract burns, and abdominal pain. Fluoride can reduce calcium levels
leading to fatal hypocalcemia. The oral human LDLo for the fluoride
ion (CAS= 16984-48-8) is 50 mg/kg. Acute fluoride intoxication
produces nausea, vomiting, abdominal pain, diarrhea and tetany,
often resulting in death from cardiovascular collapse.
Inhalation:
Causes chemical burns to the respiratory tract. Inhalation may be
fatal as a result of spasm, inflammation, edema of the larynx and
bronchi, chemical pneumonitis and pulmonary edema.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride
poisoning (fluorosis) characterized by weight loss, weakness,
anemia, brittle bones, and stiff joints.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use dry chemical.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on
skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7783-50-8:
United States OSHA: 2.5 mg/m3 TWA (as F) (listed under Fluorides
Belgium - TWA: (listed as iron salts (soluble)): 1 mg/m3 VLE (as
Malaysia: (listed as iron salts (soluble)): 1 mg/m3 TWA (as Fe)
Netherlands: (listed as iron salts (soluble)): 1 mg/m3 MAC (as Fe
Spain: (listed as iron salts (soluble)): 1 mg/m3 VLA-ED (as Fe)
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: light green
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: > 1000 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: slightly soluble in water
Specific Gravity/Density:
Molecular Formula: FeF3
Molecular Weight: 112.85
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong bases, strong acids.
Hazardous Decomposition Products:
Hydrogen fluoride gas.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7783-50-8: NO6865000
LD50/LC50:
Not available.
Carcinogenicity:
Iron(III) fluoride, anhydrous -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
USA RQ: CAS# 7783-50-8: 100 lb final RQ; 45.4 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 25 Avoid contact with eyes.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 7783-50-8: No information available.
Canada
CAS# 7783-50-8 is listed on Canada's DSL List.
CAS# 7783-50-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7783-50-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 8/21/1998 Revision #2 Date: 10/03/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
(+)-Himbacine
| 6879-74-9 |
|
Ytterbium(III) triflate hydrate, 99.9%
| 252976-51-5 |
|
Ethyl oleate, mixture of isomers, tech., 90%
| 111-62-6 |
|
Sodium hydride, 60% dispersion in mineral oil, in resealable cans
| 7646-69-7 |
|
3-(Trifluoromethyl)phenylhydrazine, tech.,, 90%
| 368-78-5 |
|
N,N'-Diaminoguanidine Monohydrochloride 98%
| 36062-19-8 |
|
Iron(III) fluoride, anhydrous, 98%
| 7783-50-8 |
|
2-Mercaptobenzothiazole, 99% (Titr.)
| 149-30-4 |
|
3-Amino-2,6-Dimethoxypyridine Monohydrochloride, 95%
| 80789-72-6 |
|
Lithium hydride, in resealable cans, 98%
| 7580-67-8 |
|
1,4-Bis(trimethylsilyl)benzene, 98%
| 13183-70-5 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 90.000
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DS=0.7)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DS=0.9)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DG=1.2)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 700000
| 9004-32-4 |
|
Tyloxapol
| 25301-02-4 |
|
4-Vinylbenzyl chloride, stabilized with 500 ppm 4-tert-butylcatechol
| 1592-20-7 |
|
Ethyl 3-phenylglycidate, 90%
| 121-39-1 |
|
2-Methyltetrahydrofuran-3-thiol
| 57124-87-5 |
|
Bis(2-methyl-3-furyl)disulphide, 98%
| 28588-75-2 |
|
2-Methylfuran-3-thiolacetate, 80%
| 55764-25-5 |
|
2-Tetrahydrofuroic acid, 99+%(gc)
| 16874-33-2 |
|
2,2,4,4,6,6-Hexamethyl-S-trithiane
| 828-26-2 |
|
MALEIC ACID, DISODIUM SALT, HYDRATE
| 371-47-1 |
|
Neurodye Di-8-ANEPPQ
| 0-01-1 |
|
Neurodye Di-12-ANEPPQ
| 0-01-1 |
|
Neurodye Di-4-ANEPPS
| 90134-00-2 |
|
Neurodye Di-8-ANEPPS
| 157134-33-7 |
|
Thallous formate, 98% (titr.)
| 992-98-3 |
|
Neurodye FM1-84
| 0-01-1 |
|
Neurodye RH-237
| 0-01-1 |
|
Neurodye RH-421
| 107610-19-5 |
|
Neurodye RH-795
| 0-01-1 |
|
Neurodye FM1-43
| 149838-22-2 |
|
Neurodye FM4-64
| 0-01-1 |
|
Neurodye FM2-10
| 0-01-1 |
|
ISOQUINOLINE-N-OXIDE
| 1532-72-5 |
|
1,3-Dithiolane-2,4,5-trithione, oligomer
| 123399-69-9 |
|
Dess-Martin periodinane, 15 wt% solution in dichloromethane
| 75-09-2 |
|
N-BENZYLIDENE-1-NAPTHYLAMINE, 97%
| 890-51-7 |
|
2-METHOXY-1-NAPHTHALENEMETHANOL
| 40696-22-8 |
|
(S)-(+)-Ibuprofen, 99%
| 51146-56-6 |
|
2-ETHOXYNAPHTHALENE, 98%
| 93-18-5 |
|
Trifluoromethanesulphinic acid potassium salt
| 41804-89-1 |
|
5-Chlorobarbituric acid
| 19645-77-3 |
|
n-Butyl (2R,3S)-(-)-2,3-epoxybutyrate, 98%
| 0-01-1 |
|
Diethyl (2R,3R)-(-)-2,3-epoxysuccinate, 98%
| 74243-85-9 |
|
Diethyl (2S,3S)-(+)-2,3-epoxysuccinate, 98%
| 73890-18-3 |
|
Benzo(e)pyrene, 99%
| 192-97-2 |
|
|